Top Markets
#1 DogBull DogBull +108.63%
#2 Siacoin Siacoin +66.67%
#3 MarsCoin MarsCoin +60.42%
#4 ADO Protocol ADO Protocol +53.58%
#5 The Bitcoin Bull The Bitcoin Bull +31.93%
#6 Ontology Gas Ontology Gas +22.49%
#7 Akedo Akedo +12.84%
#8 UnifAI Network UnifAI Network +11.47%
#9 AI XOVIA AI XOVIA +11.39%
#10 Cryptopia Cryptopia +10.51%
Coin of the day
DogBull DogBull
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Zhejiang Taimei Medical Technology Co., Ltd. Zhejiang Taimei Medical Technology Co., Ltd.

Zhejiang Taimei Medical Technology Co., Ltd.

2576
Kedudukan dalam Saham #15029
Zhejiang Taimei Medical Technology Co., Ltd., established in 2013 and based in... Zhejiang Taimei Medical Technology Co., Ltd., established in 2013 and based in Jiaxing, China, specializes in delivering sophisticated digital operational platforms specifically designed for the biopharmaceutical industry across the country. The company's core offering is TrialOS, a comprehensive digital collaboration platform that seamlessly integrates all participants throughout the drug development and research lifecycle. This ecosystem effectively links hospitals, pharmaceutical firms, external service providers, regulatory bodies, and patients, among other key industry stakeholders. Its extensive portfolio of software solutions caters to various critical aspects of clinical research and drug development. For streamlining clinical trial operations, Taimei Medical provides tools like eCooperate, which optimizes management systems and leverages big data for informed decision-making. Other related offerings include eArchives for managing master files, eCollect for electronic data capture, eCollege for training administration, eQuality for electronic audit processes, and eBalance for interactive web-based responses. Innovations such as eVisit Patient Reported Outcomes are designed to enhance patient data input and accuracy, while eTime supports project time management, and eImage facilitates medical image interpretation. Furthermore, the company supplies specialized software tailored for hospitals and Good Clinical Practice (GCP) sites. These include eTrial for managing Phase I wards, eSite and NomenCTMS for comprehensive clinical trial management at study sites, and intelligent platforms like GCP-X and Intelligent Investigator. Solutions such as eScreening assist with subject information management and deduplication, while IIT-EDC and the Investigator-Initiated Clinical Trial Management System support investigator-initiated studies and their associated data management. In the crucial domain of drug safety, the company offers robust pharmacovigilance software solutions. This includes both global and intelligent eSafety systems, alongside the SAE Manager for efficient communication and management of critical safety data during clinical trials. Complementing these, Zhejiang Taimei also develops marketing software and a variety of other digital innovation solutions.
Harga Saham
$0.67033345
Modal Pasaran
$377.97M
Perubahan (1 hari)
-3.68%
Perubahan (1 tahun)
5.38%
Negara
CN
Perdagangan Zhejiang Taimei Medical Technology Co., Ltd. (2576)

Kategori

Technology
Nisbah P/E bagi Zhejiang Taimei Medical Technology Co., Ltd. (2576)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Zhejiang Taimei Medical Technology Co., Ltd., nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi Zhejiang Taimei Medical Technology Co., Ltd. dari 2026 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
SAP SE SAP SE
SAP SE
SAP.DE
 27.13 -
DE
Salesforce, Inc. Salesforce, Inc.
Salesforce, Inc.
CRM.US
 23.41 -
US
Shopify Inc. Shopify Inc.
Shopify Inc.
SHOP.TO
 - -
CA
Uber Technologies, Inc. Uber Technologies, Inc.
Uber Technologies, Inc.
UBER.US
 16.34 -
US
ServiceNow, Inc. ServiceNow, Inc.
ServiceNow, Inc.
NOW.US
 91.92 -
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.